94 related articles for article (PubMed ID: 1339197)
1. Depression of early protection against influenza virus infection by cyclophosphamide and its restoration by protein-bound polysaccharide.
Tsuru S
Kitasato Arch Exp Med; 1992 Sep; 65(2-3):97-110. PubMed ID: 1339197
[TBL] [Abstract][Full Text] [Related]
2. Depression of early protection against influenza virus infection by cyclophosphamide and its restoration by Y-19995 [2,4'-bis(1-methyl-2-dimethyl-aminoethoxyl)-3-benzoylpyridine dimaleate].
Tsuru S; Shinomiya N; Nomoto K
Nat Immun Cell Growth Regul; 1991; 10(1):1-11. PubMed ID: 2057018
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of protection during the early phase of a generalized viral infection. II. Contribution of polymorphonuclear leukocytes to protection against intravenous infection with influenza virus.
Tsuru S; Fujisawa H; Taniguchi M; Zinnaka Y; Nomoto K
J Gen Virol; 1987 Feb; 68 ( Pt 2)():419-24. PubMed ID: 3819695
[TBL] [Abstract][Full Text] [Related]
4. The spread and persistence of influenza viruses in normal and cyclophosphamide-treated mice.
Abou-Donia H; Jennings R; Potter CW
J Med Virol; 1981; 7(4):251-62. PubMed ID: 7334358
[TBL] [Abstract][Full Text] [Related]
5. Influenza in senescent mice: impaired cytotoxic T-lymphocyte activity is correlated with prolonged infection.
Bender BS; Johnson MP; Small PA
Immunology; 1991 Apr; 72(4):514-9. PubMed ID: 2037313
[TBL] [Abstract][Full Text] [Related]
6. Neutrophils play an essential role in cooperation with antibody in both protection against and recovery from pulmonary infection with influenza virus in mice.
Fujisawa H
J Virol; 2008 Mar; 82(6):2772-83. PubMed ID: 18184718
[TBL] [Abstract][Full Text] [Related]
7. Protective mechanisms against pulmonary infection with influenza virus. I. Relative contribution of polymorphonuclear leukocytes and of alveolar macrophages to protection during the early phase of intranasal infection.
Fujisawa H; Tsuru S; Taniguchi M; Zinnaka Y; Nomoto K
J Gen Virol; 1987 Feb; 68 ( Pt 2)():425-32. PubMed ID: 3819696
[TBL] [Abstract][Full Text] [Related]
8. Ginseng and Salviae herbs play a role as immune activators and modulate immune responses during influenza virus infection.
Quan FS; Compans RW; Cho YK; Kang SM
Vaccine; 2007 Jan; 25(2):272-82. PubMed ID: 16945454
[TBL] [Abstract][Full Text] [Related]
9. Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge.
Fu TM; Guan L; Friedman A; Schofield TL; Ulmer JB; Liu MA; Donnelly JJ
J Immunol; 1999 Apr; 162(7):4163-70. PubMed ID: 10201942
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory role of neutrophils on influenza virus multiplication in the lungs of mice.
Fujisawa H
Microbiol Immunol; 2001; 45(10):679-88. PubMed ID: 11762750
[TBL] [Abstract][Full Text] [Related]
11. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
[TBL] [Abstract][Full Text] [Related]
12. Administration of inactivated and detergent-treated influenza virus to mice before virus challenge reduces mortality.
Arora DJ
J Med Virol; 1993 Sep; 41(1):85-9. PubMed ID: 8228943
[TBL] [Abstract][Full Text] [Related]
13. Dynamics of viral growth, viral enzymatic activity, and antigenicity in murine lungs during the course of influenza pneumonia.
Astry CL; Yolken RH; Jakab GJ
J Med Virol; 1984; 14(2):81-90. PubMed ID: 6491644
[TBL] [Abstract][Full Text] [Related]
14. Protection of mice against influenza virus infection: enhancement of nonspecific cellular responses by Corynebacterium parvum.
Mak NK; Schiltknecht E; Ada GL
Cell Immunol; 1983 Jun; 78(2):314-25. PubMed ID: 6861206
[TBL] [Abstract][Full Text] [Related]
15. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.
Lee KH; Seo SU; Song JM; Lee CM; Kim HA; Seong BL
Vaccine; 2006 Mar; 24(11):1966-74. PubMed ID: 16343703
[TBL] [Abstract][Full Text] [Related]
16. Respiratory diseases in cyclophosphamide-treated mice. II. Decreased virulence of PR8 influenza virus.
Singer SH; Noguchi P; Kirschstein RL
Infect Immun; 1972 Jun; 5(6):957-60. PubMed ID: 4635505
[TBL] [Abstract][Full Text] [Related]
17. Heterotypic protective immune reactions in mice infected with distinct serotypes of human influenza virus.
Floc'h F; Werner GH
Ann Microbiol (Paris); 1978; 129(4):509-24. PubMed ID: 308787
[TBL] [Abstract][Full Text] [Related]
18. Virus-like particle (VLP) vaccine conferred complete protection against a lethal influenza virus challenge.
Galarza JM; Latham T; Cupo A
Viral Immunol; 2005; 18(1):244-51. PubMed ID: 15802970
[TBL] [Abstract][Full Text] [Related]
19. Significance of long lasting persistence of influenza virus antigens at the portal of infection and in the spleen of mice.
Dubrovina TYa ; Ivanova IA; Shidlovskaya NK; Polyak RYa
Acta Virol; 1992 Oct; 36(5):450-8. PubMed ID: 1364021
[TBL] [Abstract][Full Text] [Related]
20. Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain.
de Wit E; Munster VJ; Spronken MI; Bestebroer TM; Baas C; Beyer WE; Rimmelzwaan GF; Osterhaus AD; Fouchier RA
J Virol; 2005 Oct; 79(19):12401-7. PubMed ID: 16160167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
